Humoral autoimmune responses to the squamous cell carcinoma antigen protein family in psoriasis

Journal of Investigative Dermatology

Volumn 128, Issue 9, 2008, Pages 2219-2224

  El Rachkidy, Rana G ^a   Young, Helen S ^b   Griffiths, Christopher E M ^b   Camp, Richard D R ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE 1; CYTOKERATIN 10; ENOLASE; IMMUNOGLOBULIN G; SERINE PROTEINASE INHIBITOR; SQUAMOUS CELL CARCINOMA ANTIGEN;

ARTICLE; AUTOIMMUNITY; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PSORIASIS;

EID: 49549124785     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.71     Document Type: Article

References (34)

1. Aoki S, Yaoita H, Kitajima Y (1989) An elevated level of autoantibodies against 48- to 50-kd keratins in the serum of patients with psoriasis. J Invest Dermatol 92:179-83
2. Bonetto V, Bergman AC, Jornvall H, Sillard R (1997) C-terminal sequence analysis of peptides and proteins using carboxypeptidases and mass spectrometry after derivatization of Lys and Cys residues. Anal Chem 69:1315-9
3. Boyman O, Hefti HP, Conrad C, Nickoloff BJ, Suter M, Nestle FO (2004) Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-α. J Exp Med 199:731-6
4. 4-like material in scale of psoriatic skin lesions. Br J Pharmacol 83:313-7
5. Bruch-Gerharz D, Schnorr O, Suschek C, Beck K-F, Pfeilschifter J, Ruzicka T et al. (2003) Arginase 1 overexpression in psoriasis. Limitation of inducible nitric oxide synthase as a molecular mechanism for keratinocyte hyperproliferation. Am J Pathol 162:203-11
6. Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B et al. (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25:1327-33
7. Duk JM, Van Voorst Vader PC, ten Hoor KA, Hollema H, Doeglas HM, de Bruijn HW (1989) Elevated levels of squamous cell carcinoma antigen in patients with a benign disease of the skin. Cancer 64:1652-6
8. Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RDR (1994) Elevated tumour necrosis factor-alpha (TNF-a) biological activity in psoriatic skin lesions. Clin Exp Immunol 96:146-51
9. Fincham NJ, Camp RDR, Gearing AJH, Bird CR, Cunningham FM (1988) Neutrophil chemoattractant and interleukin 1-like activity in samples from psoriatic lesions: further characterisation. J Immunol 140:4294-9
10. Fredricksson T, Pettersson U (1978) Severe psoriasis - oral therapy with a new retinoid. Dermatologica 157:238-44
11. Gearing AJH, Fincham NJ, Bird CR, Wadhwa M, Meager A, Cartwright JE et al. (1990) Cytokines in skin lesions of psoriasis. Cytokine 2:68-75
12. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H (2004) Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 135:1-8
13. Haider AS, Peters SB, Kaporis H, Cardinale I, Fei J, Ott J et al. (2006) Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia. J Invest Dermatol 126:869-81
14. Hamada K, Hanakawa Y, Hashimoto K, Iwamoto M, Kihana T, Hirose S et al. (2001) Gene expression of human squamous cell carcinoma antigens 1 and 2 in human cell lines. Oncol Rep 8:347-54
15. Harder J, Bartels J, Christophers E, Schröder J-M (1997) A peptide antibiotic from human skin. Nature 387:861-2
16. Harder J, Bartels J, Christophers E, Schröder J-M (2001) Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 276:5707-13
17. Jablonska S, Chorzelski TP, Jarzsabek-Chorzelska M, Beutner EH (1975) Studies in Immunodermatology. VII. Four-compartment system studies of IgG in stratum corneum and of stratum corneum antigen in biopsies of psoriasis and control dermatoses. Int Arch Allergy Appl Immunol 48:324-40
18. Jones DA, Yawalkar N, Suh K-Y, Sadat S, Rich B, Kupper TS (2004) Identification of autoantigens in psoriatic plaques using expression cloning. J Invest Dermatol 123:93-100
19. Kato H (1996) Expression and function of squamous cell carcinoma antigen. Anticancer Res 16:2149-53
20. Kemp EH, Herd LM, Waterman EA, Wilson AG, Weetman AP, Watson PP (2002) Immunoscreening of phage-displayed cDNA-encoded polypeptides identifies B cell targets in autoimmune disease. Biochem Biophys Res Commun 298:169-77
21. Kimura M, Tatsumi K-I, Tada H, Ikemoto M, Fukuda Y, Kaneko A et al. (2000) Enzyme immunoassay for autoantibodies to human liver-type arginase and its clinical application. Clin Chem 46:112-7
22. Kupper TS (2003) Immunologic targets in psoriasis. N Eng J Med 349:1987-90
23. Lee KH, Chung HS, Kim HS, Oh SH, Ha MK, Baik JH et al. (2003) Human alpha-enolase from endothelial cells as a target antigen of antiendothelial cell antibody in Behcet's disease. Arthr Rheum 48:2025-35
24. Masumoto K, Sakata Y, Arima K, Nakao I, Izuhara K (2003) Inhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1. J Biol Chem 278:45296-304
25. Menssen A, Trommler P, Vollmer S, Schendel D, Albert E, Gurtler L et al. (1995) Evidence for an antigen-specific cellular immune response in skin lesions of patients with psoriasis vulgaris. J Immunol 155:4078-83
26. Mitsuishi K, Nakamura T, Sakata Y, Yuyama N, Arima K, Sugita Y et al. (2005) The squamous cell carcinoma antigens as relevant biomarkers of atopic dermatitis. Clin Exp Allergy 35:1327-33
27. Payne RW. (1967) Severe outbreak of surgical sepsis due to Staphylococcus aureus of unusual type and origin. BMJ vi:17-20
28. Schmetzer O, Moldenhauer G, Riesenberg R, Pires JR, Schlag P, Pezzutto A (2005) Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: low frequency of antibodies against the natural protein. J Immunol 174:942-52
29. Schröder J-M, Christophers E (1986) Identification of C5a des arg and an anionic neutrophil-activating peptide (ANAP) in psoriatic scales. J Invest Dermatol 87:53-8
30. Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850-8
31. Suminami Y, Kishi F, Murakami A, Sakaguchi Y, Nawata S, Numa F et al. (2001) Novel forms of squamous cell carcinoma antigen transcripts produced by alternative splicing. Biochim Biophys Acta 1519:122-6
32. Takeda A, Higuchi D, Takahashi T, Ogo M, Baciu P, Goetinck PF et al. (2002) Overexpression of serpin squamous cell carcinoma antigens in psoriatic skin. J Invest Dermatol 118:147-54
33. Takematsu H, Tagami H (1992) Generation of terminal complement complexes in psoriatic lesional skin. Dermatology 185:246-50
34. Vekony MA, Holder JE, Lee AJ, Horrocks C, Eperon IC, Camp RDR (1997) Selective amplification of T cell receptor variable region species is demonstrable but not essential in early lesions of psoriasis vulgaris: analysis by anchored polymerase chain reaction and hypervariable region size spectratyping. J Invest Dermatol 109:5-13